Beam Therapeutics BEAM
NASDAQ BEAM
$24.84 -0.09 (-0.36%)
At close: Oct 21, 2026 · 4:00 PM EDT

Beam Therapeutics (BEAM) Total Debt (2026)

Updated

Beam Therapeutics (BEAM) posted Total Debt of $100.26 million for Q2 2026, up 0.1% from the prior quarter.

Analysis

Beam Therapeutics (BEAM) Total Debt (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 49.04 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 70.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 32.35 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 26.25 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 63.19 Bn
10 Beam Therapeutics 2.60 Bn -2.09 Bn - 100.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 100.26 Mn
Mar 31, 2026 100.19 Mn
API Access

Beam Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=BEAM&period=max&api_key=YOUR_API_KEY